Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 670.15
+10.00 (1.51%)
Mar 10, 2026, 3:30 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 376.36 billion as of March 10, 2026.
Market Cap
376.36B
Enterprise Value
367.15B
Revenue
20.02B
Ranking
n/a
PE Ratio
78.14
Stock Price
670.15
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has decreased from 410.17B to 376.36B, a decrease of -8.24%. That is a compound annual growth rate of -12.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 370.75B | 1.33% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 632.30B |
| OneSource Specialty Pharma | 169.70B |
| Concord Biotech | 126.29B |
| Blue Jet Healthcare | 66.84B |
| Supriya Lifescience | 50.54B |
| Zota Health Care | 40.47B |
| Dishman Carbogen Amcis | 25.75B |
| Panacea Biotec | 19.63B |